| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $81K | +0.0% |
| R&D Expense | $30.0M | -22.3% |
| SG&A Expense | $12.1M | -9.4% |
| Operating Income | -$42.1M | +18.9% |
| Net Income | -$38.2M | +21.7% |
| EPS (Basic) | -$1.27 | +30.6% |
| EPS (Diluted) | -$1.27 | +30.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.9M | -4.9% |
| Current Assets | $74.5M | -4.8% |
| Total Assets | $76.9M | -5.6% |
| Current Liabilities | $8.1M | -4.1% |
| Total Liabilities | $44.1M | -2.1% |
| Stockholders' Equity | $32.8M | -10.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.1M | +30.1% |
| Capital Expenditures | $11K | -92.8% |
| Investing Cash Flow | -$11K | +92.8% |
| Financing Cash Flow | $29.3M | +97.2% |
| Free Cash Flow | -$33.1M | +30.3% |